전기외과용 기기 시장 보고서 : 제품별, 용도별, 최종사용자별, 지역별(2026-2034년)

The global electrosurgery devices market size reached USD 7.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 10.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.44% during 2026-2034. The market is primarily driven by the increasing prevalence of chronic diseases, rising geriatric population, growing number of surgical procedures, and advancements in technology, such as improved energy control and miniaturization.

ELECTROSURGERY DEVICES MARKET ANALYSIS :

• Major Market Drivers: The continuous innovation in electrosurgery devices, such as the development of advanced energy-based systems, is driving market growth. These technologies enhance precision and reduce procedural complications, making them increasingly preferred by surgeons. Moreover, the rising incidence of chronic conditions like cancer and cardiovascular diseases are escalating the demand for electrosurgical procedures, as these devices are crucial for effective treatment.
• Key Market Trends: There is a growing trend toward integrating electrosurgical devices with minimally invasive techniques, which offer benefits like reduced recovery times and less postoperative pain. Moreover, enhanced safety features and improved device efficiency represent other major trends, with manufacturers focusing on reducing thermal damage and improving precision.
• Geographical Trends: North America dominates the market due to high healthcare expenditure, advanced healthcare infrastructure, and a significant number of elective and surgical procedures performed. Besides, Asia-Pacific is emerging as a rapidly growing market due to increased healthcare investments, rising awareness, and improvements in medical infrastructure, particularly in countries like China and India.
• Competitive Landscape: Some of the major electrosurgery devices market leaders include Applied Medical Resources Corporation, Apyx Medical Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, BOWA-electronic GmbH & Co. KG, CONMED Corporation, Erbe Elektromedizin GmbH, Johnson & Johnson, Medtronic plc, Olympus Corporation, Smith & Nephew plc and Stryker Corporation among many others.
• Challenges and Opportunities: Challenges include the high costs of advanced electrosurgery devices, the need for specialized training, and the concerns about device-related complications and regulatory policies. On the other hand, the growing demand for minimally invasive procedures presents significant opportunities for market expansion, as companies can leverage technological advancements to develop new products and address emerging needs in the healthcare sector.

ELECTROSURGERY DEVICES MARKET TRENDS :

Increasing Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular ailments is exerting a profound impact on the demand for electrosurgery devices. As chronic diseases become more widespread, the need for intricate surgical interventions increases correspondingly. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the foremost cause of death worldwide, claiming approximately 17.9 million lives annually. These disorders affect the heart and blood vessels and encompass conditions such as coronary heart disease, cerebrovascular disease, and rheumatic heart disease. Additionally, more than 4 out of 3 CVD-related deaths result from heart attacks and strokes, with one-third of these fatalities occurring prematurely in individuals under 70 years old. Besides this, electrosurgical devices, known for their precision and reduced recovery time, are increasingly preferred for surgeries related to these diseases. Hence, such devices allow surgeons to perform complex procedures with greater accuracy and less blood loss, which is particularly important in patients with chronic conditions who may face higher surgical risks.

Increase in Surgical Procedures

The increasing number of surgical procedures globally acts as a significant catalyst for the growth of the electrosurgery market. Additionally, with medical advancements and increased accessibility to healthcare services, there has been a notable surge in surgeries, ranging from minimally invasive outpatient surgeries to more complex operations. As per the National Health Service (NHS), in 2022-2023, there were 124.5 million outpatient appointments, making a 1.7% increase from the previous year. Moreover, there were 95.9 million outpatient attendances, reflecting a 0.4% increase in 2022-2023, compared to the previous year. Along with this, electrosurgery devices, which utilize electric currents to cut, coagulate, or even ablate tissue with precision, are particularly advantageous in such an environment. They offer a combination of efficiency, safety, and reduced operative times, which are crucial in high-volume surgical settings. As outpatient surgeries and elective procedures continue to increase, the reliance on efficient and adaptable surgical tools like electrosurgery devices is contributing to the market growth.

Rising Geriatric Population

The aging global population is profoundly influencing the electrosurgery devices market. Additionally, growing older adults frequently require surgical interventions due to the higher prevalence of conditions such as cancers, cardiovascular diseases, and orthopedic issues. As per the United Nations (UN), the global population of individuals aged 65 and older is expected to double, increasing from 761 million in 2021 to 1.6 billion by 2050. Electrosurgical devices cater to the needs of geriatric patients by providing safer surgical options that reduce the physical stress of surgery. Along with this, the precision of electrosurgical tools minimizes tissue damage, which is crucial for the recovery of older patients, who often have diminished healing capabilities. As the geriatric population continues to grow, the demand for surgeries tailored to their specific health requirements increases, directly driving the uptake of electrosurgical devices in healthcare settings globally.

ELECTROSURGERY DEVICES MARKET SEGMENTATION:

Breakup by Product:

• Electrosurgery Generators
• Electrosurgery Instruments and Accessories
  • Bipolar Instruments
  • Monopolar Instruments
  • Accessories
• Argon and Smoke Management Systems

Electrosurgery instruments and accessories account for the majority of the market share

Electrosurgery instruments and accessories include a variety of tools such as electrosurgical generators, active electrodes, dispersive electrodes, and various accessories that are essential for performing electrosurgical procedures. These devices are integral in surgeries that require precision cutting, coagulation, and tissue alteration. Additionally, the widespread adoption of these instruments in hospitals and clinics, driven by their effectiveness and efficiency in surgical procedures, contributes to their market growth. Hence, the continuous advancements in technology enhance the safety and outcomes of surgical interventions, thus increasing their demand in the healthcare sector. For instance, the ENSEAL X1 tissue sealers by Ethicon, a division of Johnson & Johnson MedTech, has introduced the ENSEAL X1 tissue sealers, cutting-edge bipolar electrosurgical devices designed for use with an electrosurgical generator. They are intended for cutting and sealing vessels, and cutting, grasping, and dissecting tissue during open and laparoscopic surgical procedures.

Breakup by Application:

• General Surgery
• Gynecology Surgery
• Urologic Surgery
• Orthopedic Surgery
• Cardiovascular Surgery
• Cosmetic Surgery
• Neurosurgery
• Others

General surgery holds the largest share of the industry

General surgery holds the largest market share due to the widespread adoption of electrosurgical techniques in a variety of general surgical procedures, which include incisions, dissections, and hemostasis. Additionally, general surgery encompasses a broad range of procedures that benefit significantly from the precision and reduced blood loss afforded by electrosurgical devices. These devices facilitate faster recovery times and minimize surgical risks, making them indispensable in settings ranging from emergency surgeries to planned operations. As healthcare systems globally continue to emphasize efficiency and patient safety, the integration of electrosurgery devices in general surgery is expected to grow, reinforcing its status as the largest segment in this market.

Breakup by End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

Hospitals represents the leading market segment

According to the electrosurgery devices market overview, hospitals are emerging as the predominant segment. There is an extensive adoption of advanced electrosurgical units within these settings, aimed at enhancing surgical precision and reducing procedural times. Moreover, hospitals typically have the infrastructure and financial capability to invest in high-end technology, which supports a wide range of surgical procedures including cutting, coagulating, and cauterizing tissues. Along with this, the rising number of surgeries performed in hospitals due to growing health concerns and the availability of specialized care boosts the demand for electrosurgery devices. Hence, this trend is expected to continue as hospitals expand their capabilities and integrate more technologically advanced surgical solutions. For instance, a Journal of Medical Economics, study showed the use of EES to MED for an average U.S. hospital, forecasted an annual savings of $824,760 ($101 per procedure). These savings were linked to decreased operating room time, shorter hospital stays, and lower use of disposable electrodes with Ethicon electrosurgery (EES). Also, sensitivity analyses supported these base-case results.Top of Form

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest electrosurgery devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for electrosurgery devices.

North America's dominance can be attributed to advanced healthcare infrastructure, high adoption rates of technologically sophisticated medical devices, and significant healthcare expenditure. Additionally, the presence of leading market players who continuously innovate and expand their product portfolios contributes to the region's large market share. Besides, North America continues to lead, showcasing robust growth in both research and application of electrosurgery devices. For instance, in 2023, Professor Sudip K. Mazumder, and neurosurgeon Ankit I. Mehta from the University of Illinois Health developed a method to enhance the precision of electrosurgery tools through power electronics. The interdisciplinary research was featured on the cover of IEEE Power Electronics magazine's December 2023 issue, builds on a National Institutes of Health grant led by Mazumder, titled CPS: Autonomous attainment of tissue-centricity in electrosurgery through data-driven persistently evolving thermogeometric adaptivity.

COMPETITIVE LANDSCAPE:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the electrosurgery devices industry include Applied Medical Resources Corporation, Apyx Medical Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, BOWA-electronic GmbH & Co. KG, CONMED Corporation, Erbe Elektromedizin GmbH, Johnson & Johnson, Medtronic plc, Olympus Corporation, Smith & Nephew plc, and Stryker Corporation. ()
• At present, key players in the market are adopting various strategies to strengthen their position thus creating a favorable electrosurgery devices market outlook (2024-2032). These include innovations in technology to enhance the safety and efficiency of electrosurgical procedures, which are critical in driving adoption. For instance, companies are focusing on developing devices that minimize thermal damage and improve precision. Additionally, mergers and acquisitions are enabling companies to expand their product portfolios and geographic reach. Moreover, significant investments in research and development (R&D) are made to introduce novel products that meet specific surgical needs and comply with stringent regulatory standards. Furthermore, companies are also enhancing their distribution channels and entering strategic partnerships with healthcare providers globally to increase their market penetration and accessibility, further driving market growth.

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Electrosurgery Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Electrosurgery Generators
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Electrosurgery Instruments and Accessories
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Bipolar Instruments
    • 6.2.2.2 Monopolar Instruments
    • 6.2.2.3 Accessories
  • 6.2.3 Market Forecast
• 6.3 Argon and Smoke Management Systems
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 General Surgery
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Gynecology Surgery
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Urologic Surgery
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Orthopedic Surgery
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Cardiovascular Surgery
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Cosmetic Surgery
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Neurosurgery
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast
• 7.8 Others
  • 7.8.1 Market Trends
  • 7.8.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Specialty Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Ambulatory Surgical Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Applied Medical Resources Corporation
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Apyx Medical Corporation
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 B. Braun Melsungen AG
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 SWOT Analysis
  • 14.3.4 Boston Scientific Corporation
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 BOWA-electronic GmbH & Co. KG
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 CONMED Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Erbe Elektromedizin GmbH
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Johnson & Johnson
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Medtronic plc
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Olympus Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Smith & Nephew plc
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
  • 14.3.12 Stryker Corporation
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis